Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
Authors
Marks, D. I.Kirkwood, A. A.
Rowntree, C. J.
Aguiar, M.
Bailey, K. E.
Beaton, B.
Cahalin, P.
Castleton, Anna
Clifton-Hadley, L.
Copland, M.
Goldstone, A. H.
Kelly, R.
Lawrie, E.
Lee, S.
McMillan, A. K.
McMullin, M. F.
Menne, T. F.
Mitchell, R. J.
Moorman, A. V.
Patel, B.
Patrick, P.
Smith, P.
Taussig, D.
Yallop, D.
Alapi, K. Z.
Fielding, A. K.
Affiliation
United Bristol Healthcare Trust, Bristol, UKIssue Date
2022